| Literature DB >> 33926452 |
Hao Wu1, Mengdi Fu2, Jin Liu3, Wei Chong1,4,5, Zhen Fang1,4,5, Fengying Du1, Yang Liu1, Liang Shang6,7,8, Leping Li9,10,11.
Abstract
Gastric cancer (GC) is a common tumour that affects humans worldwide, is highly malignant and has a poor prognosis. Small extracellular vesicles (sEVs), especially exosomes, are nanoscale vesicles released by various cells that deliver bioactive molecules to recipient cells, affecting their biological characteristics, changing the tumour microenvironment and producing long-distance effects. In recent years, many studies have clarified the mechanisms by which sEVs function with regard to the initiation, progression, angiogenesis, metastasis and chemoresistance of GC. These molecules can function as mediators of cell-cell communication in the tumour microenvironment and might affect the efficacy of immunotherapy. Due to their unique physiochemical characteristics, sEVs show potential as effective antitumour vaccines as well as drug carriers. In this review, we summarize the roles of sEVs in GC and highlight the clinical application prospects in the future.Entities:
Keywords: Diagnosis; Exosomes; Gastric cancer; Molecular mechanism; Small extracellular vesicles; Therapy
Year: 2021 PMID: 33926452 DOI: 10.1186/s12943-021-01365-z
Source DB: PubMed Journal: Mol Cancer ISSN: 1476-4598 Impact factor: 27.401